Portal de Periódicos da CAPES

Immediate Effect of Ultraviolet-A Collagen Cross-linking Therapy on the Biomechanics and Histology of the Human Cornea

2015; Slack Incorporated (United States); Volume: 31; Issue: 1 Linguagem: Inglês

10.3928/1081597x-20141218-08

1938-2391

M.Á. Del Buey, Elena Lanchares, José Á. Cristóbal, Santiago Ramón y Cajal, Carmen Yus Gotor, Begoña Calvo,

Ocular Surface and Contact Lens

Letters to the EditorImmediate Effect of Ultraviolet-A Collagen Cross-linking Therapy on the Biomechanics and Histology of the Human Cornea María A. del Buey, MD, , , MD Elena Lanchares, PhD, , , PhD José Ángel Cristóbal, MD, , , MD Santiago Ramón y Cajal Junquera, MD, , , MD Carmen Yus Gotor, MD, , and , MD Begoña Calvo, PhD, , PhD María A. del Buey, MD , Elena Lanchares, PhD , José Ángel Cristóbal, MD , Santiago Ramón y Cajal Junquera, MD , Carmen Yus Gotor, MD , and Begoña Calvo, PhD Published OnlineDecember 18, 2014https://doi.org/10.3928/1081597X-20141218-08Cited by:4PDFView Full Text ToolsAdd to favoritesDownload CitationsTrack Citations ShareShare onFacebookTwitterLinkedInRedditEmail SectionsMore"Immediate Effect of Ultraviolet-A Collagen Cross-linking Therapy on the Biomechanics and Histology of the Human Cornea." Journal of Refractive Surgery, 31(1), pp. 70–711.Wollensak G, Spoerl E, Seiler T. Riboflavin/ultraviolet-a-induced collagen crosslinking for the treatment of keratoconus. Am J Ophthalmol. 2003; 135:620–627. Crossref MedlineGoogle Scholar2.Wollensak G, Spoerl E, Seiler T. Stress-strain measurements of human and porcine corneas after riboflavin–ultraviolet-A-induced cross-linking. J Cataract Refract Surg. 2003; 29:1780–1785. Crossref MedlineGoogle Scholar3.Kohlhaas M, Spoerl E, Schilde T, Unger G, Wittig C, Pillunat LE. Biomechanical evidence of the distribution of cross-links in corneas treated with riboflavin and ultraviolet A light. J Cataract Refract Surg. 2006; 32:279–283. Crossref MedlineGoogle Scholar4.Raiskup F, Spoerl E. Corneal crosslinking with riboflavin and ultraviolet A: I. Principles. Ocul Surf. 2013; 11:65–74. Crossref MedlineGoogle Scholar5.Wollensak G. Histological changes in human cornea after cross-linking with riboflavin and ultraviolet A. Acta Ophthalmologica. 2010; 88:e17–e18. Crossref MedlineGoogle Scholar Previous article Next article FiguresReferencesRelatedDetailsCited byZheng X, Weng Y, Wang Y, Xin Y, Wu J, Ziad Masoud Abu Said A, Nguelemo Mayopa K, Akiti S, Li X, Wang C, Wang J, Eliasy A, Bao F, Chen S and Elsheikh A (2022) Long-term Effects of Riboflavin Ultraviolet-A–Induced CXL With Different Irradiances on the Biomechanics of In Vivo Rabbit Corneas, Journal of Refractive Surgery, 38:6, (389-397), Online publication date: 1-Jun-2022. Wang C, Fomovsky M, Miao G, Zyablitskaya M and Vukelic S (2018) Femtosecond laser crosslinking of the cornea for non-invasive vision correction, Nature Photonics, 10.1038/s41566-018-0174-8, 12:7, (416-422), Online publication date: 1-Jul-2018. Smith T, Suzuki S, Cronin B, Haghighatpanah M, Petcu E, Philippa C and Chirila T (2018) Photochemically Induced Crosslinking of Tarsal Collagen as a Treatment for Eyelid Laxity: Assessing Potentiality in Animal Tissue, Ophthalmic Plastic & Reconstructive Surgery, 10.1097/IOP.0000000000001063, 34:5, (477-482), Online publication date: 1-Sep-2018. Sadoughi M, Einollahi B, Baradaran-Rafii A, Roshandel D, Hasani H and Nazeri M (2016) Accelerated versus conventional corneal collagen cross-linking in patients with keratoconus: an intrapatient comparative study, International Ophthalmology, 10.1007/s10792-016-0423-0 Request Permissions InformationCopyright 2015, SLACK IncorporatedPDF downloadSupported by the Spanish Ministry of Education and Science Research Project DPI2011-27939-C02-01, funding from the European Union's Seven Framework Program managed by REA Research Executive agency (FP7/2007–2013) under Grant Agreement n° FP7-SME-2013 606634, and the CIBER initiative, Instituto de Salud Carlos III (ISCIII) Platform for Biological Tissue Characterization of the Centro de Investigación Biomédica en Red en Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN).The authors have no financial or proprietary interest in the materials presented herein.